Fingerprint
Dive into the research topics of 'Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically